Treatment of Inflammatory Changes on X-ray
For inflammatory changes seen on x-ray in suspected axial spondyloarthritis (axSpA), treatment should begin with NSAIDs such as naproxen as first-line therapy, followed by biologic agents like TNF-α inhibitors if NSAIDs fail to control symptoms adequately. 1, 2
Diagnostic Approach Before Treatment
Before initiating treatment, it's important to confirm the diagnosis and assess disease activity:
- Radiographs are recommended as the first imaging modality for evaluation of suspected axSpA 1
- If radiographs are negative or equivocal but clinical suspicion remains high, MRI of the sacroiliac joints is the best examination for assessment of acute inflammatory changes 1
- MRI should include T1 sequences and fat-suppressed fluid-sensitive sequences such as T2-weighted fat-suppressed or STIR images 1
- CT may be helpful when equivocal radiographic abnormalities exist, allowing identification of subtle erosions and soft-tissue ossification 1
Treatment Algorithm
First-Line Treatment
- NSAIDs are the first-line pharmacologic therapy for inflammatory changes seen on x-ray 1, 2
- Naproxen has been shown to be effective in patients with ankylosing spondylitis, decreasing night pain, morning stiffness, and pain at rest 2
- Initial dosing of naproxen is typically 375-500 mg twice daily 2
- Take NSAIDs with food to reduce gastric irritation 2, 3
Physical Measures
- Simple physical methods such as adequate rest for the injured site may be beneficial in mild cases 3
- When inflammation is controlled, therapeutic exercises should be prescribed to restore range of motion, strength, and endurance 3
Second-Line Treatment
If NSAIDs fail to adequately control symptoms after 2-4 weeks of therapy:
- Biologic agents, particularly tumor necrosis factor-α (TNF-α) antagonists, are recommended 1
- These biologics have the potential to arrest disease progression and prevent the development of disability 1
- Early diagnosis and treatment before radiographic joint damage is essential 1
Corticosteroids
- For severe acute flares, short-term corticosteroids may be considered 4
- Prednisone dosing may vary from 5 mg to 60 mg per day, depending on disease severity 4
- Corticosteroid injections may be beneficial in some cases but require precautions 3
Monitoring Disease Activity
- In adults with axSpA of unclear activity while receiving a biologic, obtaining a spinal or pelvis MRI to assess activity is conditionally recommended 1
- MRI could provide useful information in cases where the level of disease activity is unclear and where this information would influence treatment decisions 1
- For patients with nonradiographic axial SpA, imaging should focus on the sacroiliac joints 1
Important Caveats
- MRI is not recommended in patients in whom disease activity is either clearly clinically active or clinically stable 1
- In adults with stable axSpA, obtaining a spinal or pelvis MRI to confirm inactivity is not recommended 1
- Routine repeat spine radiographs at scheduled intervals (e.g., every 2 years) as a standard approach is not recommended 1
- NSAIDs may increase the risk of gastrointestinal side effects, particularly at higher doses and with prolonged use 2
- Nonsteroidal anti-inflammatory drug (NSAID) use is reported to be associated with an increase in immune checkpoint inhibitor-induced colitis, so care should be taken with NSAID use in this setting 1
Special Considerations
- For patients unable to undergo MRI, CT may be helpful, demonstrating improved sensitivity over conventional radiography for detection of subtle bone erosions and reparative changes 1
- When using biologics, screening labs (HIV, hepatitis A and B, and TB testing) should be performed initially and repeated annually in patients who require biologic treatment for more than one year 1